VoxNeuro Inc., a Hamilton-based commercial stage Software-as-a-Medical-Device (SaMD) brain health company that analyzes brain biomarkers to assess cognitive function, announced a new partnership with Boston University (“BU”), a world-class institution and private research university at the forefront of neuroscience and neurotechnology. In partnership with BU, VoxNeuro has launched two studies that will evaluate its cognitive […]
Sep-2022
Making a smart site selection could drive the commercialization of your intellectual property. Here are three examples that are helping to make Hamilton, Ontario, the next leader in life sciences research and commercialization.
Making a smart site selection could drive the commercialisation of your intellectual property. Here are three examples that are helping to make Hamilton, Ontario, the next leader in life sciences research and commercialisation. Three areas in particular, are making site selection easier: innovation parks, clinical infrastructure and supportive networks. Business location is a massive factor […]
Lactiga Therapeutics, an early-stage biotechnology company focused on improving the quality of life of patients with primary immunodeficiency diseases, announced this week that it has oversubscribed its pre-seed financing, raising $1.6 million in new capital including over $350,000 in research grants. The lead investor in the financing was 1517 Fund, and other investors include several […]
Adapsyn Bioscience Inc., a chemical bioinformatics company that discovers novel drug-like small molecules, today announced a strategic collaboration with Evotec SE. Under the collaboration, Evotec will have the opportunity to evaluate small molecules developed by Adapsyn as potential therapeutic candidates in proprietary and partnered drug discovery projects. The Adapsyn platform uses artificial intelligence and machine […]
Sep-2022
Thursday, October 6, 2022, from 10:00 am to 12:00 pm in Hamilton, Ontario Mitchel Sivilotti, President of OmniaBio, and Dr. Michael May, President and CEO of CCRM, invite you to attend OmniaBio’s groundbreaking and signing ceremony. OmniaBio will be Canada’s first and largest commercial-scale contract development and manufacturing organization (CDMO) dedicated to cell and gene therapies. […]
Aug-2022
Alex Muggah has seen hundreds of life sciences and healthtech companies work to commercialize their innovations. If new healthcare innovations don’t integrate with existing systems, there is little to no chance of mass adoption. As Director of the Synapse Life Science Consortium, a partnership of public- and private-sector institutions in Hamilton, Ontario and administrator of […]
AtomVie Global Radiopharma Inc. (AtomVie) today announced the successful closing of its Series A financing with Avego Management, LLC (“Avego”), a healthcare investment firm. AtomVie is a global leading CDMO (Contract Development and Manufacturing Organization) for the development, manufacturing, and global distribution of radiopharmaceuticals and has received a financing commitment of at least $40 million. […]
Innovative Health Diagnostics (IHD), a CLIA- and FDA-certified lab that empowers every person access to accurate, clinical testing by providing testing when and where it matters most, announced today a new partnership with AIMA Laboratories (AIMA), a Hamilton-based FemTech company dedicated to developing new products that fill current gaps in gynecological health, to develop and […]
Dr. Marc Jeschke joined McMaster University as a professor of surgery, and was also recently named vice-president of research at Hamilton Health Sciences and medical director of its burns unit. The burn trauma surgeon and scientist is moving to Hamilton from Toronto to become medical director of the burn unit at the General Hospital on […]